The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey

Journal of Clinical Virology

Volumn 47, Issue 1, 2010, Pages 65-68

  Koksal, Iftihar ^a   Yilmaz, Gurdal ^a   Aksoy, Firdevs ^a   Aydin, Hava ^a   Yavuz, Ilknur ^a   Iskender, Serap ^a   Akcay, Korhan ^a   Erensoy, Sukru ^a   Caylan, Rahmet ^a   Aydin, Kemalettin ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Crimean Congo hemorrhagic fever; Ribavirin treatment; Tick borne diseases

Indexed keywords

RIBAVIRIN;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD TRANSFUSION; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HOSPITALIZATION; HUMAN; INCUBATION TIME; INTRAVENOUS ADMINISTRATION; LEUKOCYTE COUNT; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; TICK BORNE DISEASE; TREATMENT OUTCOME; TURKEY (REPUBLIC); VIRUS HEMORRHAGIC FEVER;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTIVIRAL AGENTS; FEMALE; HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; LEUKOCYTE COUNT; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RIBAVIRIN; STATISTICS, NONPARAMETRIC; TIME FACTORS; TREATMENT OUTCOME; TURKEY;

EID: 72049111765     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2009.11.007     Document Type: Article

References (23)

1. Whitehouse C.A. Crimean-Congo hemorrhagic fever. Antiviral Res 64 3 (2004) 145-160
2. Ergonul O., Celikbas A., Baykam N., Eren S., and Dokuzoguz B. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited. Clin Microbiol Infect 12 6 (2006) 551-554
3. Ergonul O., Celikbas A., Dokuzoguz B., Eren S., Baykam N., and Esener H. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy. Clin Infect Dis 39 2 (2004) 284-287
4. Karti S.S., Odabasi Z., Korten V., Yilmaz M., Sonmez M., Caylan R., et al. Crimean-Congo hemorrhagic fever in Turkey. Emerg Infect Dis 19 8 (2004) 1379-1384
5. Ozkurt Z., Kiki I., Erol S., Erdem F., Yilmaz N., Parlak M., et al. Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. J Infect 52 3 (2006) 207-215
6. Bakir M., Ugurlu M., Dokuzoguz B., Bodur H., Tasyaran M.A., Vahaboglu H., et al. Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures. J Med Microbiol 54 4 (2005) 385-389
7. Yilmaz G.R., Buzgan T., Torunoglu M.A., Safran A., Irmak H., Com S., et al. A preliminary report on Crimean-Congo haemorrhagic fever in Turkey, March-June 2008. Euro Surveill 14 13 (2008) pii 18953
8. Borio L., Inglesby T., Peters C.J., Schmaljohn A.L., Hughes J.M., Jahrling P.B., et al. Haemorrhagic fever viruses as biological weapons. JAMA 287 18 (2002) 2391-2405
9. Koren G., King S., Knowlea S., and Philips E. Ribavirin in the treatment of SARS: a new trick for an old drug?. Can Med Assoc J 168 10 (2003) 1289-1292
10. Goad J.A., and Nuyen J. Haemorrhagic fever viruses. Top Emerg Med 25 1 (2003) 66-72
11. Fisher-Hoch S.P., Khan J.A., Rehman S., Mirza S., Khurshid M., and McCormick J.B. Crimean Congo-haemorrhagic fever treated with oral ribavirin. Lancet 346 8973 (1995) 472-475
12. Wray S.K., Gilbert B.E., Noall M.W., and Knight V. Mode of action of ribavirin: effect of nucleotide pool alterations on influenza virus ribonucleoprotein synthesis. Antiviral Res 5 1 (1985) 29-37
13. Wray S.K., Gilbert B.E., and Knight V. Effect of ribavirin triphosphate on primer generation and elongation during influenza virus transcription in vitro. Antiviral Res 5 1 (1985) 39-48
14. McCormick J.B., King I.J., Webb P.A., Scribner C.L., Craven R.B., Johnson K.M., et al. Lassa fever: effective therapy with ribavirin. N Engl J Med 314 1 (1986) 20-26
15. Paragas J., Whitehouse C.A., Bray M., and Endy T.P. A simple assay for determining antiviral activity against Crimean-Congo hemorrhagic fever virus. Antiviral Res 62 1 (2004) 21-25
16. Ergonul O. Treatment of Crimean-Congo hemorrhagic fever. Antiviral Res 78 1 (2008) 125-131
17. Mardani M., and Jahromi M.K. Crimean-Congo haemorrhagic fever. Arch Iranian Med 10 2 (2007) 204-214
18. Mardani M., Jahromi M.K., Naieni K.H., and Zeinali M. The efficacy of oral ribavirin in the treatment of Crimean-Congo haemorrhagic fever in Iran. Clin Infect Dis 36 12 (2003) 1613-1618
19. Ergonul O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis 6 4 (2006) 203-214
20. Cevik M.A., Elaldi N., Akinci E., Ongürü P., Erbay A., Buzgan T., et al. A preliminary study to evaluate the effect of intravenous ribavirin treatment on survival rates in Crimean-Congo hemorrhagic fever. J Infect 57 4 (2008) 350-351
21. Graci J.D., and Cameron C.E. Mechanisms of action of ribavirin against distinct viruses. Rev Med Virol 16 1 (2006) 37-48
22. Heagy W., Crumpacker C., Lopez P.A., and Finberg R.W. Inhibition of immune functions by antiviral drugs. J Clin Invest 87 6 (1991) 1916-1924
23. Izadi S., and Salehi M. Evaluation of the efficacy of ribavirin therapy on survival of Crimean-Congo hemorrhagic fever patients: a case-control study. Jpn J Infect Dis 62 1 (2009) 11-15